[Yakup] C&R Healthcare Global (Thailand), the Thai subsidiary of C&R Research, and KIMCo signed an MOU to ‘Develop TBM in the ASEAN region’
C&R Healthcare Global (Thailand) Co., Ltd., the Thai subsidiary of C&R Research, and KIMCo(Korea Innovative Medicines Consortium) signed an MOU to ‘Develop TBM in the ASEAN region’.
For the key points of the MOU include,
– Supporting clinical trials in Thailand (including manpower and technical support)
– Regulatory cooperation for new drugs and Technology Based Medicines (TBM) in Thailand and other ASEAN countries
– Establishing networks between C&R Thailand and Korean pharmaceutical and biotech companies
C&R Research, established its Thai subsidiary last year, providing cost-effective and high-quality clinical trial services.
Dr. Prapan Jutavijittum, Managing Director of C&R Thailand, remarked, “We look forward to supporting many Korean sponsors in conducting clinical trials in Thailand and the ASEAN region. This partnership presents a great opportunity to deliver cost-effective, high-quality multinational clinical trial services.”
Please check out further details by following the link below.
